Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial
- 7 April 2001
- Vol. 322 (7290) , 826
- https://doi.org/10.1136/bmj.322.7290.826
Abstract
Objective: To compare chemotherapy given at home with outpatient treatment in terms of colorectal cancer patients' safety, compliance, use of health services, quality of life, and satisfaction with treatment. Design: Randomised controlled trial. Setting: Large teaching hospital. Participants: 87 patients receiving adjuvant or palliative chemotherapy for colorectal cancer. Interventions: Treatment with fluorouracil (with or without folinic acid or levamisole) at outpatient clinic or at home. Main outcome measures: Treatment toxicity; patients' compliance with treatment, quality of life, satisfaction with care, and use of health resources. Results: 42 patients were treated at outpatient clinic and 45 at home. The two groups were balanced in terms of age, sex, site of cancer, and disease stage. Treatment related toxicity was similar in the two groups (difference 7% (95% confidence interval −12% to 26%)), but there were more voluntary withdrawals from treatment in the outpatient group than in the home group (14% v 2%, difference 12% (1% to 24%)). There were no differences between groups in terms of quality of life scores during and after treatment. Levels of patient satisfaction were higher in the home treatment group, specifically with regard to information received and nursing care. There were no significant differences in use of health services. Conclusions: Home chemotherapy seemed an acceptable and safe alternative to hospital treatment for patients with colorectal cancer that may improve compliance and satisfaction with treatment. What is already known on this topic Home chemotherapy programmes have been proposed as an alternative to hospital treatment However, they are more costly, and there is little evidence on their impact on outcomes such as compliance, quality of life, or use of other health services What this study adds Home chemotherapy was not associated with an increased use of health services such as primary care or emergency departments Home chemotherapy had no effect on patients' quality of life but increased their compliance with treatment and satisfaction, particularly with regard to nursing care Home chemotherapy seems an acceptable and safe alternative to outpatient treatment that may improve compliance with treatmentKeywords
This publication has 14 references indexed in Scilit:
- A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis.2000
- Home or Hospital? An Evaluation of the Costs, Preferences, and Outcomes of Domiciliary ChemotherapyInternational Journal of Health Services, 2000
- The health and cost effects of substituting home care for inpatient acute care: a review of the evidence.1999
- Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic reviewBMJ, 1998
- The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy.Journal of Clinical Oncology, 1988
- Day hospital as an alternative to inpatient care for cancer patients: A random assignment trialJournal of Clinical Epidemiology, 1988
- Development of Scales to Measure Satisfaction and Preferences Regarding Long-Term and Terminal CareMedical Care, 1984
- Therapeutic compliance and the cancer patient.1984
- Compliance and cancer chemotherapy.BMJ, 1983
- Compliance with cancer therapy by patients and physiciansThe American Journal of Medicine, 1983